news
03-03-2022, 10:09 PM
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants | NEJM (https://news.google.com/__i/rss/rd/articles/CBMiM2h0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTW9hMjExMDI3NdIBAA?oc=5) nejm.orgView Full Coverage on Google News (https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2lXNm 8zM0JCSHVaSU5sMFcyY3N5Z0FQAQ?oc=5)
More... (https://news.google.com/__i/rss/rd/articles/CBMiM2h0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTW9hMjExMDI3NdIBAA?oc=5)
More... (https://news.google.com/__i/rss/rd/articles/CBMiM2h0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTW9hMjExMDI3NdIBAA?oc=5)